D. Desai

发表

Cough due to asthma, cough-variant asthma and non-asthmatic eosinophilic bronchitis.

C. Brightling, D. Desai, 2010, Otolaryngologic clinics of North America.

Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma

S. Gupta, C. Brightling, S. Visvanathan, 2013, Respiratory Research.

P122 The use of impulse oscillometry (IOS) to study fractal scaling and sample entropy in airway resistance time series in severe asthma

C. Brightling, S. Siddiqui, A. Singapuri, 2010, Thorax.

Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.

I. Pavord, F. Symon, A. Sousa, 2013, American journal of respiratory and critical care medicine.

COPD Cytokines IL-17 A and IL-17 F in Asthma and Expression of the T Helper 17-Associated

M. Bafadhel, M. Sleeman, S. Siddiqui, 2010 .

Severe asthma: a consequence of over exuberant repair?

C. Brightling, D. Desai, S. Siddiqui, 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Aspergillus fumigatus during stable state and exacerbations of COPD

I. Pavord, C. Brightling, A. Wardlaw, 2013, European Respiratory Journal.

Reply: Role of primary necrosis/lysis of submucosal eosinophils in obese individuals with asthma.

C. Brightling, D. Desai, 2013, American journal of respiratory and critical care medicine.

Tumor Necrosis Factor Alpha

C. Brightling, L. Chachi, Y. Amrani, 2011 .

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.

I. Pavord, B. Hargadon, C. Brightling, 2012 .

S32 Hierarchical cluster analysis of subjects with severe asthma according to microbiological profile

M. Barer, V. Mistry, S. Diver, 2018, Mucosal and microbial drivers of asthma.

Reply: Elevated sputum IL-5 and submucosal eosinophilia in obese individuals with severe asthma.

C. Brightling, D. Desai, 2014, American journal of respiratory and critical care medicine.

Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease

I. Pavord, P. Burton, C. Newby, 2015, The Journal of allergy and clinical immunology.

S91 Aspergillus fumigatus sensitisation in patients with chronic obstructive pulmonary disease

I. Pavord, C. Brightling, A. Wardlaw, 2011, Thorax.

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).

I. Pavord, B. Hargadon, C. Brightling, 2014, The Journal of allergy and clinical immunology.

TNF-alpha antagonism in severe asthma?

C. Brightling, D. Desai, 2010, Recent patents on inflammation & allergy drug discovery.

CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration

S. Gupta, C. Brightling, R. Saunders, 2014, Allergy.

S80 Localisation of the site of fixed airflow obstruction in moderate to severe asthma using hyperpolarised helium-3 MRI

C. Brightling, S. Gonem, P. Gustafsson, 2011, Thorax.

Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum

C. Newby, B. Hargadon, C. Brightling, 2019, BMC Pulmonary Medicine.

S115 NADPH Oxidase 4 Over-Expression Mediates Epithelial Ciliary Dysfunction in Neutrophilic Asthma

C. Brightling, M. Barer, R. Hirst, 2012, Thorax.

Evidence for phenotype-driven treatment in asthmatic patients

C. Brightling, S. Gonem, S. Siddiqui, 2011, Current opinion in allergy and clinical immunology.

Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles

I. Pavord, S. Johnston, C. Brightling, 2018, Journal of Allergy and Clinical Immunology.

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1

I. Pavord, B. Hargadon, C. Brightling, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.

I. Pavord, B. Hargadon, C. Brightling, 2010, American journal of respiratory and critical care medicine.

Can inhaled corticosteroids prevent asthma exacerbations?

C. Brightling, S. Siddiqui, D. Desai, 2011, Current opinion in pulmonary medicine.

Cytokines and cytokine-specific therapy in asthma.

C. Brightling, D. Desai, 2012, Advances in clinical chemistry.

Expression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD

C. Brightling, M. Bafadhel, M. Sleeman, 2010, Chest.

Sputum mediator profiling in severe asthma: relationships with clinical phenotypes, airway inflammation and morphometry in stable disease and at exacerbations

D. Desai, 2016 .

Airway impedance entropy and exacerbations in severe asthma

C. Brightling, S. Gonem, S. Siddiqui, 2012, European Respiratory Journal.

NADPH Oxidase-4 Overexpression Is Associated With Epithelial Ciliary Dysfunction in Neutrophilic Asthma

C. Brightling, P. Andrew, A. Wardlaw, 2016, Chest.

Cytokine and anti‐cytokine therapy in asthma: ready for the clinic?

C. Brightling, D. Desai, 2009, Clinical and experimental immunology.

Clinical significance of small airway obstruction markers in patients with asthma

R. Costanza, P. Bradding, S. Gonem, 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Fibrocyte localisation to the ASM bundle in asthma: bidirectional effects on cell phenotype and behaviour

C. Brightling, S. Siddiqui, L. Chachi, 2020, Clinical & translational immunology.

Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus‐predominant subgroup

I. Pavord, C. Brightling, M. Barer, 2019, Allergy.

Sputum Inflammatory Mediators Are Increased in Aspergillus fumigatus Culture-Positive Asthmatics

C. Brightling, A. Wardlaw, L. Rapley, 2016, Allergy, asthma & immunology research.

Clinical significance of small airway obstruction markers in patients with asthma

S. Gonem, R. Costanza, A. Singapuri, 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Cough due to asthma, cough-variant asthma and non-asthmatic eosinophilic bronchitis.

C. Brightling, D. Desai, 2010, Otolaryngologic clinics of North America.

Evidence for phenotype-driven treatment in asthmatic patients

C. Brightling, S. Gonem, S. Siddiqui, 2011, Current opinion in allergy and clinical immunology.